Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): Mexico

Código QR

Awareness of Abdominal Adiposity as a Cardiometabolic Risk Factor (The 5A Study): Mexico

Daniel Cuevas Ramos1, Roopa Mehta1, Julieta De La Luz Castro2, Rutila Casta&ntilde;eda Limones3, Ernesto Garc&iacute;a Rub&iacute;4, Carlos A Aguilar-Salinas11Department of Endocrinology, Instituto Nacional de Ciencias Medicas y Nutricion &quot;Salvador Zubiran&am...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Garcia-Rubi E, De La Luz-Castro J, Mehta R, Cuevas-Ramos D, Aguilar-Salinas CA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/2a9d25fda9d4448ea859baf6ec789b4d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
por: Boodai SA, et al.
Publicado: (2014)

The prevalence of adverse cardiometabolic responses to exercise training with evidence-based practice is low
por: Dalleck LC, et al.
Publicado: (2015)

Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis
por: Savva SC, et al.
Publicado: (2013)

Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
por: Sweeting AN, et al.
Publicado: (2014)

Hepatic function and the cardiometabolic syndrome
por: Wiernsperger N
Publicado: (2013)

Cardiometabolic results from an armband-based weight loss trial
por: Sieverdes JC, et al.
Publicado: (2011)

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
por: Da Costa LA, et al.
Publicado: (2012)

Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders
por: Estampador AC, et al.
Publicado: (2014)

Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
por: Oh S, et al.
Publicado: (2014)

Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity
por: Benatti FB, et al.
Publicado: (2011)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Stanley Schwartz, et al.
Publicado: (2010)

Can reducing sitting time in the university setting improve the cardiometabolic health of college students?
por: Butler KM, et al.
Publicado: (2018)

Specific cut-off points for waist circumference and waist-to-height ratio as predictors of cardiometabolic risk in Black subjects: a cross-sectional study in Benin and Haiti
por: EL Mabchour A, et al.
Publicado: (2015)

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years
por: MacConell L, et al.
Publicado: (2013)

Central adiposity and the propensity for rehearsal in children
por: Ling FCM, et al.
Publicado: (2011)

Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton
por: Bovet P, et al.
Publicado: (2011)

Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes
por: Sasakabe T, et al.
Publicado: (2011)

Negative association of acetate with visceral adipose tissue and insulin levels
por: Layden BT, et al.
Publicado: (2012)

Adipose inflammation: cause or consequence of obesity-related insulin resistance
por: Haiyan Xu, et al.
Publicado: (2008)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US
por: McQueen RB, et al.
Publicado: (2016)

Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study
por: Strassnig M, et al.
Publicado: (2012)

Prevalence of abdominal obesity in Abia State, Nigeria: results of a population-based house-to-house survey
por: Chukwuonye II, et al.
Publicado: (2013)

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
por: Zambad SP, et al.
Publicado: (2013)

ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with Insulin Resistance in Obesity [Corrigendum]
por: Vincent V, et al.
Publicado: (2019)

Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial
por: Nagatomo A, et al.
Publicado: (2015)

The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study
por: Gaita L, et al.
Publicado: (2019)

Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease
por: Hung MC, et al.
Publicado: (2020)

Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents
por: Sebekova K, et al.
Publicado: (2020)

HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
por: Kowall B, et al.
Publicado: (2013)

Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
por: Hirales-Tamez O, et al.
Publicado: (2012)

Long Non-Coding RNAs in Brown Adipose Tissue
por: Lai S, et al.
Publicado: (2020)

Significant increment in the prevalence of overweight and obesity documented between 1994 and 2008 in Mexican college students
por: H Garc&iacute;a-Alcala, et al.
Publicado: (2010)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
por: Ogedengbe OS, et al.
Publicado: (2015)

Past, present, and future: Critical analysis of use of gastric bands in obese patients
por: Brad Snyder, et al.
Publicado: (2010)

The humanistic and economic burden associated with increasing body mass index in the EU5
por: Gupta S, et al.
Publicado: (2015)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Giuseppe Derosa, et al.
Publicado: (2009)

Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial
por: Cuevas-Ramos D, et al.
Publicado: (2013)

Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
por: Fu L, et al.
Publicado: (2015)

Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome
por: Smith CJ, et al.
Publicado: (2015)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Pamela Kushner
Publicado: (2010)